Era Finance Powers RNA Innovation: $9.4M Funding Boost for Terrain Bio's Next-Gen RNA Manufacturing Breakthrough

We are excited to announce a transformative funding milestone that will accelerate our vision at Terrain Bio. In a robust funding round led by Era Finance, we successfully raised $9,400,000—a testament to our innovative approach and commitment to revolutionizing RNA therapeutics manufacturing. At Terrain Bio, we help RNA therapeutics companies design and build better RNA, faster, by leveraging the latest innovations in protein and RNA design along with the deep expertise of our scientific cofounders. With this fresh injection of capital, we are poised to elevate our research and development efforts, enhance our state-of-the-art manufacturing capabilities, and expand our exceptional team of scientists and engineers. This strategic investment will enable us to push the boundaries of RNA production efficiency, quality, and speed, ultimately driving the rapid delivery of breakthrough therapeutics to patients in need. Our renewed focus will be on refining our proprietary processes and scaling our operations to meet the growing demands of the industry, fueling collaboration with promising partners and fueling further innovation across our product pipelines. We view this funding not only as a significant milestone but also as a vote of confidence in our vision and technological expertise. As we embark on this new chapter, our dedicated team is more determined than ever to set new standards in RNA design and manufacturing, paving the way for life-saving treatments and a brighter future in biotech. With Era Finance’s support, Terrain Bio is ready to lead the charge towards more agile, efficient, and groundbreaking RNA therapeutics solutions.